HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-trimethylaminoethylmethacrylate chitosan

used to form antigen-conjugated nanoparticles

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acrylates: 212
      - Methacrylates: 609
        N-trimethylaminoethylmethacrylate chitosan: 1
Macromolecular Substances: 97
- Polymers: 13051
  - Biopolymers: 773
    - Chitin: 898
      - Chitosan: 6494
        N-trimethylaminoethylmethacrylate chitosan: 1
Carbohydrates: 22023
- Polysaccharides: 15383
  - Chitin: 898
    - Chitosan: 6494
      - N-trimethylaminoethylmethacrylate chitosan: 1

Experts

1.	Jiang, Xinguo: 1 article (11/2015)
2.	Liu, Qingfeng: 1 article (11/2015)
3.	Shao, Xiayan: 1 article (11/2015)
4.	Zhang, Chi: 1 article (11/2015)
5.	Zhang, Qizhi: 1 article (11/2015)
6.	Zhang, Xi: 1 article (11/2015)
7.	Zheng, Xiaoyao: 1 article (11/2015)

Related Diseases

1.

Human Influenza (Influenza)

11/01/2015 - "In this study, we covalently conjugated an influenza A (H1N1) antigen to the surface of N-trimethylaminoethylmethacrylate chitosan (TMC) nanoparticles (H1N1-TMC/NP) through thioester bonds to increase the immunogenicity of the antigen after nasal administration. "
11/01/2015 - "Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration."

Related Drugs and Biologics

1.	Antigens

Related Therapies and Procedures

1.	Intranasal Administration